Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H18ClNO4 |
| Molecular Weight | 347.793 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)N(CCCC(O)=O)C(=O)C2=CC=C(Cl)C=C2
InChI
InChIKey=VUPBWNXFSDRWJE-UHFFFAOYSA-N
InChI=1S/C18H18ClNO4/c1-24-16-10-8-15(9-11-16)20(12-2-3-17(21)22)18(23)13-4-6-14(19)7-5-13/h4-11H,2-3,12H2,1H3,(H,21,22)
Clanobutin is a choleretic drug. It increases the secretion of bile by hepatocytes. Clanobutin sodium has been introduced as a choleretic and digestant agent for animals. It has been used in all domestic animals in which enhancement of digestion and all associated secretory processes are indicated. Clanobutin was reported to induce a demonstrable increase in the secretory activity of the exocrine digestive glands and in the excretion of the bile.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA16QA05
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
||
|
NCI_THESAURUS |
C66913
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB06639MIG
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
3104
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
W6Y945055S
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
100000080169
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
DTXSID10184628
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
m3607
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
250-232-3
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
C77837
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
2907
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
35378
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107589
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
30544-61-7
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY | |||
|
C019159
Created by
admin on Mon Mar 31 18:16:59 GMT 2025 , Edited by admin on Mon Mar 31 18:16:59 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
